1. Home
  2. BNTC vs LMNR Comparison

BNTC vs LMNR Comparison

Compare BNTC & LMNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • LMNR
  • Stock Information
  • Founded
  • BNTC 1995
  • LMNR 1893
  • Country
  • BNTC United States
  • LMNR United States
  • Employees
  • BNTC N/A
  • LMNR N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • LMNR Farming/Seeds/Milling
  • Sector
  • BNTC Health Care
  • LMNR Consumer Staples
  • Exchange
  • BNTC Nasdaq
  • LMNR Nasdaq
  • Market Cap
  • BNTC 356.6M
  • LMNR 291.1M
  • IPO Year
  • BNTC N/A
  • LMNR N/A
  • Fundamental
  • Price
  • BNTC $15.36
  • LMNR $15.79
  • Analyst Decision
  • BNTC Strong Buy
  • LMNR Hold
  • Analyst Count
  • BNTC 7
  • LMNR 1
  • Target Price
  • BNTC $24.71
  • LMNR $23.00
  • AVG Volume (30 Days)
  • BNTC 40.0K
  • LMNR 71.1K
  • Earning Date
  • BNTC 05-14-2025
  • LMNR 06-09-2025
  • Dividend Yield
  • BNTC N/A
  • LMNR 1.90%
  • EPS Growth
  • BNTC N/A
  • LMNR N/A
  • EPS
  • BNTC N/A
  • LMNR 0.43
  • Revenue
  • BNTC N/A
  • LMNR $186,077,000.00
  • Revenue This Year
  • BNTC N/A
  • LMNR N/A
  • Revenue Next Year
  • BNTC N/A
  • LMNR $11.90
  • P/E Ratio
  • BNTC N/A
  • LMNR $36.96
  • Revenue Growth
  • BNTC N/A
  • LMNR 2.39
  • 52 Week Low
  • BNTC $5.74
  • LMNR $14.80
  • 52 Week High
  • BNTC $16.90
  • LMNR $29.22
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 61.26
  • LMNR 47.58
  • Support Level
  • BNTC $13.01
  • LMNR $15.13
  • Resistance Level
  • BNTC $16.55
  • LMNR $16.18
  • Average True Range (ATR)
  • BNTC 1.13
  • LMNR 0.52
  • MACD
  • BNTC 0.21
  • LMNR 0.07
  • Stochastic Oscillator
  • BNTC 72.00
  • LMNR 40.99

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

Share on Social Networks: